• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Isoniazid acetylation rate and development of antinuclear antibodies upon isoniazid treatment.

作者信息

Alarcón-Segovia D, Fishbein E, Alcalá H

出版信息

Arthritis Rheum. 1971 Nov-Dec;14(6):748-52. doi: 10.1002/art.1780140610.

DOI:10.1002/art.1780140610
PMID:5316358
Abstract
摘要

相似文献

1
Isoniazid acetylation rate and development of antinuclear antibodies upon isoniazid treatment.异烟肼乙酰化速率及异烟肼治疗后抗核抗体的产生
Arthritis Rheum. 1971 Nov-Dec;14(6):748-52. doi: 10.1002/art.1780140610.
2
[Clinical pharmacology of isoniazid (a review of the literature)].[异烟肼的临床药理学（文献综述）]
Probl Tuberk. 1979 Jan(1):18-26.
3
The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis.异烟肼乙酰化代谢表型在肺结核治疗中的潜在临床意义。
Tubercle. 1984 Sep;65(3):211-27. doi: 10.1016/0041-3879(84)90079-5.
4
[Determination of the phenotype of INH inactivation in pulmonary tuberculosis by means of an indirect method on the model of sulfamethazine].[以磺胺二甲嘧啶为模型，采用间接法测定肺结核中异烟肼失活的表型]
Pneumonol Pol. 1978 Aug;46(8):605-12.
5
[The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].[异烟肼乙酰化酶表型在肺结核治疗中的潜在临床意义]
Cas Lek Cesk. 1984 Feb 10;123(6):158-64.
6
Levels of acetyl hydrazines and rate of acetylation of isoniazid in adult tuberculosis patients.
Indian J Physiol Pharmacol. 1985 Apr-Jun;29(2):83-8.
7
[Type of isoniazid (INH) acetylation determined in tuberculosis patients treated at the Institute of Tuberculosis and Lung Diseases in Warsaw during the years 1990-1997].[1990年至1997年期间在华沙结核病与肺部疾病研究所接受治疗的结核病患者中异烟肼（INH）乙酰化类型的测定]
Pneumonol Alergol Pol. 2002;70(3-4):180-92.
8
Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis.三千名南印度患者在接受异烟肼治疗结核病期间，肝毒性与乙酰化代谢表型之间不存在相关性。
Am Rev Respir Dis. 1984 Jan;129(1):58-61. doi: 10.1164/arrd.1984.129.1.58.
9
[Rate of acetylation of isoniazid in pulmonary tuberculosis and its relationship with effect and side-effects of treatment (author's transl)].
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi. 1981 Dec;4(6):349-51.
10
[Lupus induced by isoniazid].[异烟肼诱发的狼疮]
Ann Pediatr (Paris). 1972 Jun-Jul;19(6):459-68.

引用本文的文献

1
Drug-induced lupus erythematosus: an update on drugs and mechanisms.药物诱导性红斑狼疮：药物和机制的最新研究进展。
Curr Opin Rheumatol. 2018 Sep;30(5):490-497. doi: 10.1097/BOR.0000000000000522.
2
HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients.HIV-1合并感染不会降低南非结核病门诊患者对利福平、异烟肼和吡嗪酰胺的暴露。
Antimicrob Agents Chemother. 2016 Sep 23;60(10):6050-9. doi: 10.1128/AAC.00480-16. Print 2016 Oct.
3
Acetylator phenotype and lupus erythematosus.
乙酰化酶表型与红斑狼疮
Clin Pharmacokinet. 1981 Mar-Apr;6(2):118-34. doi: 10.2165/00003088-198106020-00003.
4
Blood protein conjugates and acetylation of aromatic amines. New findings on biological monitoring.血液蛋白结合物与芳香胺的乙酰化作用。生物监测的新发现。
Int Arch Occup Environ Health. 1985;56(3):179-96. doi: 10.1007/BF00396596.
5
Genetically determined variability in acetylation and oxidation. Therapeutic implications.乙酰化和氧化的基因决定变异性。治疗意义。
Drugs. 1985 Apr;29(4):342-75. doi: 10.2165/00003495-198529040-00003.
6
Drug-induced antinuclear antibodies and lupus syndromes.药物性抗核抗体与狼疮综合征
Drugs. 1976;12(1):69-77. doi: 10.2165/00003495-197612010-00003.
7
Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype.采用高效液相色谱法同时分析氨苯砜和单乙酰氨苯砜：一种快速测定乙酰化代谢表型的方法。
Br J Clin Pharmacol. 1978 Nov;6(5):421-7. doi: 10.1111/j.1365-2125.1978.tb04606.x.
8
Disease and acetylation polymorphism.疾病与乙酰化多态性
Clin Pharmacokinet. 1977 May-Jun;2(3):182-97. doi: 10.2165/00003088-197702030-00003.